期刊文献+

MMC方案预处理后异基因外周血造血干细胞移植治疗慢性粒细胞白血病

MMC Conditioning Regimen (Melphalan, MeCCNU and Cyclophosphomide) Followed by Allogeneic Peripheral Blood Stem Cells Transplantation for Chronic Myeloid Leukemia
暂未订购
导出
摘要 为进一步探讨慢性粒细胞白血病(CML)的治疗,对3例CML患者采用HLA相合同胞兄妹异基因外周血干细胞移植治疗,预处理方案为马法兰(M)170mg/m2×1,甲环亚硝脲(M)400mg/m2×1,环磷酰胺(C)60mg/kg×2。供者造血干细胞动员用重组人粒细胞集落刺激因子300μg/d×6,血细胞分离机连续采集外周血单个核细胞,其中CD34+细胞为12.8~20.0×106/kg,CFU-GM集落数为3.5~4.3×105/kg。结果显示:移植后患者中性粒细胞恢复达≥0.5×109/L,+14~+20天;血小板≥2.0×109/L在+16~+34天。移植后+100天骨髓染色体核型分析:2例完全嵌合,Ph1(-),1例部分嵌合(73%为供者核型),外周血和骨髓检查正常。结果表明,HLA相合同胞兄妹异基因外周血干细胞移植采集方便,重建造血功能快;MMC预处理方案对白血病细胞的清除和保证移植物存活均有作用,且移植相关毒性低。 This paper reports 3 cases of allogeneic peripheral blood stem cell transplantation (Allo PBSCT) for the patients with chronic myeloid leukemia (CML). The patients received MMC preparative regimen with high dose chemotherapy (Melphalan 170mg/m 2, po. on Day-5, MeCCNU 400mg/m 2, po.on Day-4, and Cyclophosphomide 60mg/kg/day, iv. on Days-3 and -2). The HLA identical sibling donors received filgrastim (rhG CSF) for mobilization at a dose of 300μg/day for 6 days. Leukaphereses were done at the 6th day of mobilization. A median of 8000ml (2 times total blood volume) of blood was processed the collecting: 2.5 4.5×10 8/kg MNC, 12.8 20.0×10 6/kg CD34 +cells (including 4.8 7.5×10 6/kg CD34 +CD33 -, 8.0 13 0×10 6/kg CD34 +CD33 +), and 3.5 4.3×10 5/kg CFU GM. Cyclosporin A and methotrexate were used for GVHD prophylaxis. Hematopoitic function recovered as for 14-20 days to >0.5×10 9/L of neutrophil count, and for 16-34 days to >20×10 9/L of platelet count. At day +100, chromosome analysis of bone marrow cells showed that complete chimera without ph 1 positive chromosome in Cases 1 and 3, and a partial chimera with 73% donor karyotype in Case 2. All patients now are in disease free survival. No episode of acute graft versus host disease (GVHD) developed. It was concluded that HLA matched sibling allogeneic PBSCT result in rapid hematopoitic reconstitution and the MMC conditioning regimen is effective both in leukemic cells eradication and in immunosuppression for stem cells engraftment, and the drug related toxicity could be tolerated by patients.
出处 《华西医科大学学报》 CSCD 1998年第4期407-410,共4页 Journal of West China University of Medical Sciences
关键词 造血干细胞移植 慢性 粒细胞 白血病 ALLO-PBSCT Allogeneic peripheral blood stem cell transplantation Chronic myeloid leukemia Melphalan MeCCNU Cyclophosphomide
  • 相关文献

参考文献1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部